文献速递心血管CT

零冠状动脉钙化积分患者的CTA斑块特征与急性冠脉综合征风险:ICONIC试验启示

CTA-Derived Plaque Characteristics and Risk of Acute Coronary Syndrome in Patients With Coronary Artery Calcium Score of Zero: Insights From the ICONIC Trial.
PubMed 文献 · AJR Am J Roentgenol · 2025-04-30

本研究为ICONIC试验的回顾性二次分析,纳入216例倾向性匹配的症状性患者(ACS组与对照组各108例),用人工智能软件行CTA定量斑块评估。ACS组中23%的患者CAC积分为0;在CAC0亚组中,ACS患者与对照组的纤维斑块、纤维脂肪斑块及坏死核心斑块体积均有显著差异。

要点

  • ACS组中23%(25/108)的患者CAC积分为0,提示CAC0不能排除ACS风险。
  • CAC0亚组中,ACS患者纤维斑块体积29.4±42.0 vs 对照组5.5±15.2 mm³(p<.001)。
  • CAC0亚组中,ACS患者纤维脂肪斑块27.3±52.2 vs 1.3±3.7 mm³,坏死核心2.8±6.4 vs 0.0±0.1 mm³(均p<.001)。

核心结论

  • 倾向性评分匹配后,23%的ACS患者CAC积分为0;CAC0的ACS与对照组患者非钙化斑块成分体积存在显著差异。

研究设计与样本

  • ICONIC试验的回顾性二次分析,源自CONFIRM国际多中心前瞻性注册研究(2004年1月至2010年5月),纳入216例倾向性匹配的症状性患者(ACS组与对照组各108例),采用人工智能软件行CTA自动定量斑块评估,ACS组以有创血管造影识别罪犯病变。

关键影像表现/征象

  • CAC0与CAC>0的ACS患者罪犯病变在纤维斑块、纤维脂肪斑块及坏死核心斑块体积上无显著差异(p>.05)。
  • CAC0亚组中,ACS患者较对照组纤维斑块体积更大(29.4±42.0 vs 5.5±15.2 mm³,p<.001)。
  • CAC0亚组中,ACS患者较对照组纤维脂肪斑块体积更大(27.3±52.2 vs 1.3±3.7 mm³,p<.001)。
  • CAC0亚组中,ACS患者较对照组坏死核心斑块体积更大(2.8±6.4 vs 0.0±0.1 mm³,p<.001)。

诊断标准与关键数值

  • CAC积分0定义为CAC0,CAC积分大于0定义为CAC>0。
  • CAC0亚组中纤维斑块体积ACS组29.4±42.0 mm³ vs 对照组5.5±15.2 mm³(p<.001)。
  • CAC0亚组中纤维脂肪斑块体积ACS组27.3±52.2 mm³ vs 对照组1.3±3.7 mm³(p<.001)。
  • CAC0亚组中坏死核心斑块体积ACS组2.8±6.4 mm³ vs 对照组0.0±0.1 mm³(p<.001)。

临床应用与阅片要点

  • 识别和量化非钙化斑块形态的方法可能有助于表征CAC0症状性患者的ACS风险。

局限性

  • 本研究为对既往前瞻性注册研究数据的回顾性二次分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Coronary artery calcium (CAC) scoring is used to stratify acute coronary syndrome (ACS) risk. Nonetheless, patients with a CAC score of zero (CAC0) remain at risk from noncalcified plaque components. OBJECTIVE. The purpose of this study was to explore CTA-derived coronary artery plaque characteristics in symptomatic patients with CAC0 who subsequently have ACS through comparisons with patients with a CAC score greater than 0 (CAC> 0) who subsequently have ACS as well as with patients with CAC0 who do not subsequently have ACS. METHODS. This study entailed a secondary retrospective analysis of prior prospective registry data. The international multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry collected longitudinal observational data on symptomatic patients who underwent clinically indicated coronary CTA from January 2004 to May 2010. ICONIC (Incident Coronary Syndromes Identified by CT) was a nested cohort study conducted within CONFIRM that identified patients without known coronary artery disease (CAD) at the time of CTA who did and did not subsequently have ACS (i.e., the ACS and control groups, respectively) and who were propensity matched in a 1:1 ratio on the basis of CAD risk factors and CAD severity on CTA. The present ICONIC substudy selected matched patients in the ACS and control groups who both had documented CAC scores. CTA examinations were analyzed using artificial intelligence software for automated quantitative plaque assessment. In the ACS group, invasive angiography findings were used to identify culprit lesions. RESULTS. The present study included 216 patients (mean age, 55.6 years; 91 women and 125 men), with 108 patients in each of the ACS and control groups. In the ACS group, 23% (n = 25) of patients had CAC0. In the ACS group, culprit lesions in the subsets of patients with CAC0 and CAC> 0 showed no significant differences in fibrous, fibrofatty, or necrotic-core plaque volumes (p > .05). In the CAC0 subset, patients with ACS, compared with control patients, had greater mean (± SD) fibrous plaque volume (29.4 ± 42.0 vs 5.5 ± 15.2 mm3, p < .001), fibrofatty plaque volume (27.3 ± 52.2 vs 1.3 ± 3.7 mm3, p < .001), and necrotic-core plaque volume (2.8 ± 6.4 vs 0.0 ± 0.1 mm3, p < .001). CONCLUSION. After propensity-score matching, 23% of patients with ACS had CAC0. Patients with CAC0 in the ACS and control groups showed significant differences in volumes of noncalcified plaque components. CLINICAL IMPACT. Methods that identify and quantify noncalcified plaque forms may help characterize ACS risk in symptomatic patients with CAC0.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Jonas RA, Nurmohamed NS, Crabtree TR, et al. CTA-Derived Plaque Characteristics and Risk of Acute Coronary Syndrome in Patients With Coronary Artery Calcium Score of Zero: Insights From the ICONIC Trial. AJR Am J Roentgenol. 2025. PMID: 40304673. doi:10.2214/AJR.24.31476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。